Pharmanovia A/S: Financial statements 2018
CVR: 32287824
Source: annual report 2018, Danish Business Authority
01/04/2017 – 31/03/2018
Pharmanovia A/S (CVR 32287824) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 2,645,762 and a net result of DKK -9,237,568. Equity in the 2018 report amounted to DKK -14,039,366. The company had 8 employees in the financial year.
- Gross Profit
- DKK 2,645,762
- Profit/Loss
- DKK -9,237,568
- Equity
- DKK -14,039,366
- Total Assets
- DKK 23,903,228
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 2.6 mio. | -9.2 mio. | -14 mio. | 8 |
| 2015 | - | 1.5 mio. | -2.2 mio. | -12.3 mio. | 4 |
| 2014 | - | -609 t. | -3.4 mio. | -10.2 mio. | 4 |
| 2013 | - | -1.2 mio. | -6.7 mio. | -6.8 mio. | - |
| 2012 | - | -157 t. | -586 t. | -60 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of February 28, 2018, is registered as an owner of Pharmanovia A/S with an ownership share of 100%.
About Pharmanovia A/S
Pharmanovia A/S is a Danish company of the type Aktieselskab based in København S, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Atnahs Pharma Nordics A/S and PHARMANOVIA A/S. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. The company has 3 employees (2026). In 2026, the company reported a gross profit of EUR 11,734,813 and a net result of EUR 7,730,657 compared with DKK 3,839,334 the year before. Equity in the 2026 report amounted to EUR 15,820,601.
